NPPB and hydrops fetalis: For HF, N-terminal pro-brain natriuretic peptide (NT-proBNP) is regarded as the gold-standard biomarker for diagnosis (Leto et al., 2016), while soluble suppression of tumorigenicity-2 (sST2) has been shown to help predict adverse outcomes (Mueller and Dieplinger, 2016).